Yokohama, Japan

Michie Nakatuka

This inventor holds 2 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1987-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michie Nakatuka. Retrieved from https://idiyas.com/inventor/michie-nakatuka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1987-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michie Nakatuka: Innovator in Semicarbazide Derivatives

Introduction

Michie Nakatuka is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of chemistry, particularly in the development of semicarbazide derivatives. With a total of 2 patents to her name, her work has garnered attention in the pharmaceutical industry.

Latest Patents

Nakatuka's latest patents include innovative processes for the preparation of semicarbazide derivatives. One of her notable inventions is a compound of the formula: ##STR1## wherein R.sup.1 is hydrogen. This advancement has potential applications in various chemical processes. Another patent focuses on new semicarbazide derivatives, further showcasing her expertise in this area.

Career Highlights

Nakatuka is currently employed at Fujisawa Pharmaceutical Company, Ltd., where she continues to push the boundaries of pharmaceutical research. Her work has not only contributed to her company's success but has also advanced the field of medicinal chemistry.

Collaborations

Throughout her career, Nakatuka has collaborated with esteemed colleagues such as Norihiko Shimazaki and Yoshio Kawai. These partnerships have enriched her research and led to innovative solutions in her field.

Conclusion

Michie Nakatuka is a trailblazer in the development of semicarbazide derivatives, with a promising career in pharmaceutical innovation. Her contributions are paving the way for future advancements in chemistry and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…